Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Innoviva, Inc.(INVA) | 7,277,000 | 2,816,022 | -4,460,978 | $126.26M | $51.05M | 33.00% | -$75.20M |
| Neurocrine Biosciences, Inc.(NBIX) | 309,116 | 309,116 | 0 | $42.19M | $34.19M | 22.10% | -$8.01M |
| Cytokinetics, Incorporated(CYTK) | 833,799 | 600,000 | -233,799 | $39.22M | $24.11M | 15.59% | -$15.11M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 16,390,000 | 0 | $72.61M | $24.09M | 15.57% | -$48.51M |
| Amarin Corp PlcADR | 24,850,623 | 24,850,623 | 0 | $12.05M | $11.14M | 7.20% | -$917.0K |
| Lantheus Holdings, Inc.(LNTH) | 63,000 | 100,000 | +37,000 | $5.64M | $9.76M | 6.31% | +$4.12M |
| Vor Biopharma Inc.(VOR) | 618,000 | 508,016 | -109,984 | $686.0K | $364.5K | 0.24% | -$321.5K |
| Gilead Sciences, Inc.(GILD) | 262,080 | 0 | -262,080 | $24.21M | $0 | — | -$24.21M |